Income StatementBalance SheetCash FlowSegments
Abbott logo

Abbott Cash Flow Statement

Operating, investing, and financing cash movements

Abbott generated $9.5B in operating cash flow over the trailing twelve months. After $2.1B in capital expenditures, free cash flow was $7.4B. Free cash flow increased 0.1% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$9.5BNet Cash From Investing (TTM)-$22.3BNet Cash From Financing (TTM)$13.1BCapital Expenditures (TTM)$2.1BDepreciation And Amortization Cf (TTM)$1.4BNet Change In Cash (TTM)$248.0M
Latest FilingQ1 2026
Report Date2026-04-29
Market Cap$152.25B
P/E Ratio24.26
ROE12.44%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions and In-Process R&D$0.0$0.0$30.0M$55.0M$20.0M$19.8B
Proceeds from sale of other investments$7.0M$750.0K$750.0K$750.0K$750.0K—
Capital expenditures$720.0M$484.0M$502.0M$496.0M$689.0M$399.0M
Proceeds from Sale of Other Investments$7.0M$750.0K$750.0K$750.0K$750.0K—
Payment for (Proceeds from) Other Investing Activity-$4.0M-$6.0M-$2.0M-$4.0M-$6.0M-$34.0M
Proceeds from other investments$7.0M$750.0K$750.0K$750.0K$750.0K—
Net cash from investing activities-$866.0M-$470.0M-$582.0M-$457.0M-$913.0M-$20.3B
Net Payments for or Proceeds from Investments—-$8.0M$52.0M-$90.0M—$161.0M
Purchases of investments$42.3M$41.8M$41.8M$41.8M$41.8M—
Proceeds from Sale of Other Investments$7.0M$750.0K$750.0K$750.0K$750.0K—

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Investing and Financing Gains (Losses), Net-$120.5M-$16.3M-$16.3M-$16.3M-$16.3M—
Change in accounts receivable$158.0M$262.0M$410.0M$202.0M—$42.0M
Change in inventories—$255.0M——-$234.0M$420.0M
Other working capital changes—$436.0M$244.0M——$420.0M
Net cash from operating activities$2.9B$1.4B$2.0B$2.8B$3.3B$1.3B
Net income$9.2B$1.3B$1.8B$1.6B$1.8B$1.1B
Amortization of capitalized software and acquired intangible assets$465.0M$420.0M$420.0M$420.0M$422.0M$422.0M
Depreciation$342.0M$336.0M$357.0M$371.0M$370.0M$381.0M
Increase (Decrease) in Prepaid Expense and Other Assets$199.0M$323.8M$323.8M$323.8M$323.8M—
Stock-based compensation$111.0M$289.0M$142.0M$120.0M$113.0M$317.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from issuance of debt$1.0M$1.0M$2.0M$0.0$2.0M$19.9B
Repayments of debt$640.0M$1.0B$1.0M$501.0M$1.0M$1.4B
Dividends paid$958.0M$1.0B$1.0B$1.0B$1.0B$1.1B
Proceeds from (Repayments of) Short-Term Debt—-$36.0M-$16.0M$0.0-$71.0M$31.0M
Net cash from financing activities-$1.9B-$2.1B-$1.1B-$1.8B-$1.4B$17.3B
Proceeds from issuance of common stock$25.0M$287.0M$35.0M$69.0M$5.0M$116.0M
Repurchases of common stock$315.0M$280.0M$6.0M$305.0M$302.0M$180.0M
Net Change in Short-term Borrowings and Indebtedness to Subsidiaries—-$36.0M-$16.0M$0.0-$71.0M$31.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$2.1B$933.0M$1.5B$2.3B$2.6B$916.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$83.0M$24.0M$51.0M—$6.0M-$23.0M
Net increase (decrease) in cash$58.0M-$1.1B——$1.0B-$1.7B

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income Taxes Paid, Net$430.8M$483.3M$483.3M$483.3M$483.3M—